Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics
LB Travis, SD Fossa, HD Sesso… - Journal of the …, 2014 - academic.oup.com
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: New paradigms for translational genomics
LB Travis, SD Fossa, HD Sesso… - Journal of the …, 2014 - mayoclinic.elsevierpure.com
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics
LB Travis, SD Fossa, HD Sesso… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
[PDF][PDF] Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics
LB Travis, SD Fossa, HD Sesso, RD Frisina… - 2014 - academia.edu
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.
LB Travis, SD Fossa, HD Sesso, RD Frisina… - Journal of the …, 2014 - europepmc.org
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: New paradigms for translational genomics
LB Travis, SD Fossa, HD Sesso… - Journal of the …, 2014 - mdanderson.elsevierpure.com
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
[PDF][PDF] Chemotherapy-Induced Peripheral neurotoxicity and ototoxicity: new Paradigms for translational Genomics
LB Travis, SD Fossa, HD Sesso, RD Frisina… - 2014 - researchgate.net
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
[HTML][HTML] Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics
LB Travis, SD Fossa, HD Sesso… - JNCI Journal of the …, 2014 - ncbi.nlm.nih.gov
In view of advances in early detection and treatment, the 5-year relative survival rate for all
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …
cancer patients combined is now approximately 66%. As a result, there are more than 13.7 …